Related Experiment Videos
Antibiotic prophylaxis in recurrent erysipelas
A C Sjöblom1, B Eriksson, C Jorup-Rönström
1Dept. of Infectious Diseases, Huddinge Hospital, Sweden.
Infection
|November 1, 1993
Summary
Daily antibiotic prophylaxis may reduce erysipelas recurrence in patients with circulation issues. Continuous prophylaxis is indicated for those with a high rate of recurrent erysipelas infections.
Area of Science:
- Infectious Diseases
- Dermatology
- Pharmacology
Background:
- Recurrent erysipelas is common in patients with impaired local circulation.
- Interventions targeting circulation may benefit these patients.
- Antibiotic prophylaxis is a potential strategy to reduce erysipelas recurrence.
Purpose of the Study:
- To evaluate the efficacy of daily antibiotic prophylaxis in reducing erysipelas recurrence.
- To assess the impact of continuous antibiotic prophylaxis on patients with venous insufficiency or lymphatic congestion.
Main Methods:
- Prospective, randomized, open-label study.
- Inclusion criteria: ≥2 erysipelas episodes in 3 years, venous insufficiency or lymphatic congestion.
- Follow-up using life table analysis over a median of 15 months.
Main Results:
- Daily antibiotic prophylaxis showed a trend towards reduced erysipelas recurrence (p = 0.06).
- Phenoxymethylpenicillin was the primary prophylactic agent; erythromycin used for penicillin allergies.
- The effect of prophylaxis was not statistically dramatic but suggested a benefit.
Conclusions:
- Continuous antibiotic prophylaxis against erysipelas is indicated for patients experiencing a high recurrence rate.
- Further research may be needed to confirm the efficacy in broader patient populations.
- Management of underlying circulatory impairment remains crucial in preventing erysipelas.